Results 231 to 240 of about 7,421,514 (390)

Next‐generation proteomics improves lung cancer risk prediction

open access: yesMolecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj   +4 more
wiley   +1 more source

Assessing Fungal Biodiversity Using Molecular Markers

open access: hybrid, 2017
Md. Shamim   +5 more
openalex   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

open access: yesMolecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller   +17 more
wiley   +1 more source

Molecular markers associated with elevated colorectal cancer risk: a mini review. [PDF]

open access: yesHered Cancer Clin Pract
Szuman M   +9 more
europepmc   +1 more source

MOLECULAR MARKER AIDED SELECTION FOR NOVEL TRAITS IN KOMADAN COCONUT PALMS FOR PRODUCING QUALITY SEEDLINGS

open access: green, 2020
A M Shahiba   +4 more
openalex   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

GLUT and FAPα as molecular markers for interstitial lung disease in systemic sclerosis. [PDF]

open access: yesRespir Res
Broens B   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy